(Q24316495)

positive regulation of apoptotic process

GOA release 2020-03-11

1 reference

Secreted frizzled-related protein 1

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Peter V N Bodine

1

0 references

Barbara Stauffer

2

0 references

Helga Ponce-de-Leon

3

0 references

Ramesh A Bhat

4

0 references

Annamarie Mangine

5

0 references

Laura M Seestaller-Wehr

6

0 references

Robert A Moran

7

0 references

Julia Billiard

8

0 references

Shoichi Fukayama

9

0 references

Barry S Komm

10

0 references

Keith Pitts

11

0 references

Girija Krishnamurthy

12

0 references

Ariamala Gopalsamy

13

0 references

Mengxiao Shi

14

0 references

Jeffrey C Kern

15

0 references

Thomas J Commons

16

0 references

Richard P Woodworth

17

0 references

Matthew A Wilson

18

0 references

Gregory S Welmaker

19

0 references

Eugene J Trybulski

20

0 references

William J Moore

Secreted Frizzled-related proteins: searching for relationships and patterns

21

0 references

language of work or name

English

0 references

publication date

June 2009

0 references

published in

Bone

0 references

volume

44

0 references

issue

6

0 references

page(s)

1063-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Structure-function analysis of secreted frizzled-related protein-1 for its Wnt antagonist function

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Reduced relative risk of fractures among users of lithium

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Wnt signaling and osteoblastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Lithium use and the risk of fractures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Wnt signaling in osteoblasts and bone diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Regulated expression of sFRP-1 protein by the GeneSwitch system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

A Wnt canon orchestrating osteoblastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Pharmacological inhibitors of glycogen synthase kinase 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Wnt signaling: a key regulator of bone mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Identification of diarylsulfone sulfonamides as secreted frizzled related protein-1 (sFRP-1) inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Dickkopf-1 is a master regulator of joint remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

How many drug targets are there?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

WNT and beta-catenin signalling: diseases and therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Structural and Kinetic Studies of a Cisplatin-modified DNA Icosamer Binding to HMG1 Domain B

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Canonical WNT Signaling Promotes Osteogenesis by Directly StimulatingRunx2Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Regulation of secreted Frizzled-related protein-1 by heparin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Stimulation of bone formation in vitro and in rodents by statins

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

The Wnt signaling pathway in development and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Regulation of bone mass by Wnt signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

5-Lipoxygenase metabolites inhibit bone formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Secreted antagonists of the Wnt signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

LRP5 and Wnt signaling: a union made for bone

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Small-molecule modulators of Hh and Wnt signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

Wnt/beta-catenin signaling pathway as a novel cancer drug target

1 reference

https://api.crossref.org/works/10.1016%2FJ.BONE.2009.02.013

7 January 2021

10.1016/J.BONE.2009.02.013

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19254787

1 reference

Consolidated OpenCitations Corpus – April 2017